ArticleJournal of the American Heart Association2025
Towards Phenotyping Characteristics and Mechanism of Conduction Delay in Patients With Nonischemic Heart Failure With Reduced Ejection Fraction: Insights From Cardiac Magnetic Resonance Imaging.
Article in Journal of the American Heart Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundConsidering that 30% to 40% of patients do not benefit from cardiac resynchronization therapy implantation, it is insufficient to evaluate patients with heart failure with reduced ejection fraction solely based on QRS duration and morphology for guiding cardiac resynchronization therapy decisions and prognosis. A crucial step in addressing this issue is conducting a comprehensive pathophysiological assessment to understand the mechanisms underlying dyssynchrony and inefficient cardiac contraction. This study aims to utilize cardiac magnetic resonance imaging to explore underlying pathophysiological impairments in patients with heart failure with reduced ejection fraction with different QRS morphologies, seeking to identify better indicators for clinical assessment.
methodsA retrospective analysis was conducted on 887 consecutive patients with nonischemic heart failure with reduced ejection fraction and prolonged QRS duration who underwent cardiac magnetic resonance imaging, as well as 200 subjects with heart failure with reduced ejection fraction and normal QRS duration as the control group.
resultsPatients with left bundle-branch block (LBBB) had a reduced left ventricular/right ventricular ejection fraction ratio compared with controls and patients with right bundle- branch block (RBBB) (LBBB versus RBBB versus controls: 0.6 [0.5, 0.8] versus 0.8 [0.6, 1.1] versus 0.8 [0.6, 1.1]). Late gadolinium enhancement percentage and extracellular volume fraction were significantly larger in patients with RBBB and nonspecific intraventricular conduction delay than in controls and patients with LBBB. Patients with LBBB or intraventricular conduction delay were associated with more impaired left ventricular torsion (LBBB versus intraventricular conduction delay versus RBBB: 0.3°/cm [-0.3, 0.5] versus 0.4°/cm [0.2, 0.7] versus 0.5°/cm [0.2, 0.8]) and strains than those with RBBB. Multivariable logistic regression revealed that the left ventricular/right ventricular ejection fraction ratio and torsion were independent determinants of LBBB.
conclusionsA reduced left ventricular/right ventricular ejection fraction ratio and impaired left ventricular torsion may serve as valuable predictors of dyssynchrony, potentially identifying patients most likely to benefit from cardiac resynchronization therapy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.